1. Home
  2. CPAC vs DCTH Comparison

CPAC vs DCTH Comparison

Compare CPAC & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPAC
  • DCTH
  • Stock Information
  • Founded
  • CPAC 1949
  • DCTH 1988
  • Country
  • CPAC Peru
  • DCTH United States
  • Employees
  • CPAC N/A
  • DCTH N/A
  • Industry
  • CPAC Building Materials
  • DCTH Medical/Dental Instruments
  • Sector
  • CPAC Industrials
  • DCTH Health Care
  • Exchange
  • CPAC Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • CPAC 512.9M
  • DCTH 485.5M
  • IPO Year
  • CPAC 2012
  • DCTH N/A
  • Fundamental
  • Price
  • CPAC $6.15
  • DCTH $12.50
  • Analyst Decision
  • CPAC Sell
  • DCTH Strong Buy
  • Analyst Count
  • CPAC 2
  • DCTH 4
  • Target Price
  • CPAC $6.20
  • DCTH $24.00
  • AVG Volume (30 Days)
  • CPAC 9.6K
  • DCTH 785.8K
  • Earning Date
  • CPAC 07-21-2025
  • DCTH 08-04-2025
  • Dividend Yield
  • CPAC 8.15%
  • DCTH N/A
  • EPS Growth
  • CPAC 15.59
  • DCTH N/A
  • EPS
  • CPAC 0.13
  • DCTH N/A
  • Revenue
  • CPAC $545,786,617.00
  • DCTH $53,850,000.00
  • Revenue This Year
  • CPAC N/A
  • DCTH $155.42
  • Revenue Next Year
  • CPAC N/A
  • DCTH $37.93
  • P/E Ratio
  • CPAC $9.35
  • DCTH N/A
  • Revenue Growth
  • CPAC 2.78
  • DCTH 1068.87
  • 52 Week Low
  • CPAC $5.10
  • DCTH $7.17
  • 52 Week High
  • CPAC $6.65
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • CPAC 66.09
  • DCTH 33.81
  • Support Level
  • CPAC $5.82
  • DCTH $13.30
  • Resistance Level
  • CPAC $6.65
  • DCTH $14.15
  • Average True Range (ATR)
  • CPAC 0.15
  • DCTH 0.64
  • MACD
  • CPAC 0.02
  • DCTH -0.26
  • Stochastic Oscillator
  • CPAC 45.65
  • DCTH 8.28

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: